Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Jean Le Reste

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Plos One|April 23, 2020
Optimization of time frame binning for FDOPA uptake quantification in gliomaAntoine Girard, Hervé Saint-Jalmes, Nibras Chaboub, et al.
Journal of Neuro-Oncology|October 23, 2021
Combining <sup>18</sup>F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled studyAntoine Girard, Pierre-Jean Le Reste, Alice Metais, et al.
EMBO Reports|March 12, 2021
Reflux of Endoplasmic Reticulum proteins to the cytosol inactivates tumor suppressorsDaria Sicari, Federica G Centonze, Raphael Pineau, et al.
Neurourology and Urodynamics|August 3, 2018
Comparison of neurogenic lower urinary tract dysfunctions in open versus closed spinal dysraphism: A prospective cross-sectional study of 318 patientsBenoit Peyronnet, Charlène Brochard, Magali Jezequel, et al.
Clinical Nuclear Medicine|June 13, 2022
Delayed [ 18 F]-FDG PET Imaging Increases Diagnostic Performance and Reproducibility to Differentiate Recurrence of Brain Metastases From RadionecrosisHosameldin Otman, Julien Farce, Pierre Meneret, et al.
Cancer Letters|September 4, 2020
Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivoPierre Jean Le Reste, Raphael Pineau, Konstantinos Voutetakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
CD90 Expression Controls Migration and Predicts Dasatinib Response in GlioblastomaTony Avril, Amandine Etcheverry, Raphaël Pineau, et al.
Journal of Neuro-Oncology|July 21, 2017
Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?Marc Zanello, Alexandre Roux, Renata Ursu, et al.
Neurocritical Care|March 29, 2023
Clipping Versus Coiling for Ruptured MCA Aneurysms Associated with Intracerebral Hematoma Requiring Surgical EvacuationThomas Metayer, Chloe Dumot, Florian Bernard, et al.
Journal of Neuro-Oncology|March 29, 2023
Natural history of spinal cord metastasis from brain glioblastomasAymeric Amelot, Louis-Marie Terrier, Gabrielle Cognacq, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Plos One|April 23, 2020
Optimization of time frame binning for FDOPA uptake quantification in gliomaAntoine Girard, Hervé Saint-Jalmes, Nibras Chaboub, et al.
Journal of Neuro-Oncology|October 23, 2021
Combining <sup>18</sup>F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled studyAntoine Girard, Pierre-Jean Le Reste, Alice Metais, et al.
EMBO Reports|March 12, 2021
Reflux of Endoplasmic Reticulum proteins to the cytosol inactivates tumor suppressorsDaria Sicari, Federica G Centonze, Raphael Pineau, et al.
Neurourology and Urodynamics|August 3, 2018
Comparison of neurogenic lower urinary tract dysfunctions in open versus closed spinal dysraphism: A prospective cross-sectional study of 318 patientsBenoit Peyronnet, Charlène Brochard, Magali Jezequel, et al.
Clinical Nuclear Medicine|June 13, 2022
Delayed [ 18 F]-FDG PET Imaging Increases Diagnostic Performance and Reproducibility to Differentiate Recurrence of Brain Metastases From RadionecrosisHosameldin Otman, Julien Farce, Pierre Meneret, et al.
Cancer Letters|September 4, 2020
Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivoPierre Jean Le Reste, Raphael Pineau, Konstantinos Voutetakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
CD90 Expression Controls Migration and Predicts Dasatinib Response in GlioblastomaTony Avril, Amandine Etcheverry, Raphaël Pineau, et al.
Journal of Neuro-Oncology|July 21, 2017
Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?Marc Zanello, Alexandre Roux, Renata Ursu, et al.
Neurocritical Care|March 29, 2023
Clipping Versus Coiling for Ruptured MCA Aneurysms Associated with Intracerebral Hematoma Requiring Surgical EvacuationThomas Metayer, Chloe Dumot, Florian Bernard, et al.
Journal of Neuro-Oncology|March 29, 2023
Natural history of spinal cord metastasis from brain glioblastomasAymeric Amelot, Louis-Marie Terrier, Gabrielle Cognacq, et al.
Pageof 4